Celebrating 20 Years of Growth and Innovation

As Beaufort celebrates its 20th anniversary, we reflect on the journey that has shaped our organization. Beaufort was founded in 2004 with a vision to redefine the standards of service and excellence in the clinical research arena and to act as a valued partner for our clients. Today, we are proud  that our dedication to these ideals has resulted in helping hundreds of clients make significant advancements in the development of diagnostic, medical device, and pharmaceutical products. As a leading global contract research organization (CRO) with team members in over 60 countries, we have helped our clients advance human health through the rapid development and commercialization of innovative products.

While we have grown substantially since those early days, the heart of Beaufort’s core values and principles remain the same. We are a CRO deeply committed to always prioritizing the needs and goals of our clients, driven by a shared sense of interest and passion in their success. This is manifested across all of our operations and solutions, from clinical trial services and regulatory affairs to data sciences, quality assurance, and clinical monitoring oversight. However, this commitment extends beyond providing expertise and service; it is about fostering enduring partnerships built on trust and transparency.

In reaching this milestone, we want to express our gratitude to all of the clients that entrusted Beaufort with their life science projects. We recognize the responsibility that comes with this decision and are honored to partner with you in delivering innovative products to help transform healthcare. Drawing on our collective experience spanning over 1,000 clinical trials and 500 regulatory submissions, we will continuously embrace emerging technologies and methodologies across all facets of our business operations. We also look forward to embarking on new ventures across the life science spectrum including novel approaches in companion diagnostics for precision medicine, early cancer detection, as well as deeper integration of artificial intelligence (AI), real-world evidence (RWE) / real-world data (RWD) and digital health technologies that will further advance innovation.

Finally, we extend our appreciation to the exceptional employees who are industry leaders in their own right. These talented individuals not only excel in their respective fields but also embody the collaborative spirit that defines our organizational culture. By working together as a cohesive team, they confront and overcome the most complex challenges with ingenuity and perseverance. It is their unwavering commitment to excellence and forward-thinking that fuels our growth and momentum.

It is a great honor to be part of an organization that has accomplished so much over the past two decades. Thank you all for your partnerships and contributions, and we look forward to many years ahead as we continue to deliver excellence in meeting the dynamic needs of clients and the patients we all ultimately serve.

View all news & insights